ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 171 filers reported holding ASCENDIS PHARMA A/S in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $86 | -34.8% | 631 | -28.0% | 0.00% | – |
| Q1 2024 | $132 | +91.3% | 876 | +61.0% | 0.00% | – |
| Q4 2023 | $69 | +35.3% | 544 | 0.0% | 0.00% | – |
| Q3 2023 | $51 | +4.1% | 544 | 0.0% | 0.00% | – |
| Q2 2023 | $49 | -15.5% | 544 | 0.0% | 0.00% | – |
| Q1 2023 | $58 | -99.4% | 544 | +597.4% | 0.00% | – |
| Q1 2022 | $9,000 | -10.0% | 78 | 0.0% | 0.00% | – |
| Q4 2021 | $10,000 | -16.7% | 78 | 0.0% | 0.00% | – |
| Q3 2021 | $12,000 | +20.0% | 78 | 0.0% | 0.00% | – |
| Q2 2021 | $10,000 | 0.0% | 78 | 0.0% | 0.00% | – |
| Q1 2021 | $10,000 | – | 78 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 2,003,147 | $225,574,000 | 20.44% |
| RA Capital Management | 4,914,955 | $553,473,000 | 17.48% |
| Sofinnova Investments, Inc. | 1,109,874 | $124,983,000 | 11.56% |
| Eversept Partners, LP | 275,494 | $31,023,379 | 7.71% |
| Avoro Capital Advisors LLC | 1,787,000 | $201,234,000 | 6.79% |
| Orbimed Advisors | 3,287,400 | $370,194,000 | 6.22% |
| Eventide Asset Management | 1,698,648 | $191,285,000 | 6.19% |
| Logos Global Management LP | 120,000 | $13,513,000 | 5.14% |
| Ghost Tree Capital, LLC | 150,000 | $16,892,000 | 4.48% |
| Spyglass Capital Management LLC | 351,388 | $39,570,000 | 4.47% |